Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to evaluate the safety and tolerance of ClinOleic or Lipoplus or SMOFlipid lipid emulsions. After 6 weeks of each lipid emulsion, Omegaven (fish oil) was added for a further 4 weeks. The safety and tolerance was evaluated after each lipid emulsion cycle by biochemistry, hematology and coagulation variables, vital signs and adverse events. We also analysed fatty acid profiles in plasma or erythrocyte phospholipids, antioxidant enzyme activities, lipid peroxidation products, plasma lipids and pro-inflammatory cytokine production after in vitro stimulation of whole blood by lipopolysacharide in HPN patients. The non-interventional group of healthy controls was included for comparison.


Clinical Trial Description

Intravenous lipid emulsions (LEs) are an indispensable part of home parenteral nutrition (HPN). All commercially obtainable LEs are applicable for HPN in providing a source of energy and essential fatty acids. The originally used soyabean oil-based LE (Intralipid) have been suspected of being associated with a higher risk of pro-inflammatory lipid-mediator production due to their high content of n-6 polyunsaturated fatty acids. The more modern mixes of soyabean oil, and/or olive oil, and/or fish oil LEs with beneficial responses compared with Intralipid are available. Given that there are no clear clinical recommendations for LE application in HPN, we performed this cross-over design, phase 4 study comparing ClinOleic, Lipoplus or SMOFlipid in chronic intestinal failure patients with additional escalation of fish oil using Omegaven. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03149653
Study type Interventional
Source General University Hospital, Prague
Contact
Status Completed
Phase Phase 4
Start date January 15, 2012
Completion date June 30, 2016

See also
  Status Clinical Trial Phase
Recruiting NCT03606863 - Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS Phase 3
Completed NCT00451646 - Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition Phase 3
Completed NCT04006730 - Analysis of the Pharmaceutical Validation of Picc Line Installation Requests at the Nîmes University Hospital
Enrolling by invitation NCT06161350 - The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
Completed NCT04234152 - Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study N/A
Completed NCT00672854 - Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN Phase 2/Phase 3
Active, not recruiting NCT01839617 - Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery N/A
Completed NCT05299099 - Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301 Phase 3
Withdrawn NCT02463812 - Lipid Infusion Following Major Surgery N/A
Completed NCT04816734 - Initial Parenteral Nutrition Education of Parent Assessment Plan N/A
Terminated NCT01814956 - Different Lipid Emulsions in Acute Lung Injury Patients Phase 4
Completed NCT04234490 - Longitudinal Evaluation of the Impact of Parenteral Nutrition
Recruiting NCT05519761 - A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
Completed NCT00321165 - The AOT (Acridine Orange and Taurolidine) Trial Phase 3
Completed NCT00292279 - The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients Phase 3
Recruiting NCT03157245 - Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery N/A
Recruiting NCT03693287 - Personalized vs Standardized PN for Preterm Infants >1250g Phase 4
Completed NCT02828150 - Integrative Parenteral Nutrition in Cancer Patients N/A
Completed NCT00798681 - Evaluating the Influence of Ready-to-use (RTU) Parenteral Nutrition in the Clinical Outcome of Patients Study Phase 4
Completed NCT00512629 - Cholestasis Prevention: Efficacy of IV Fish Oil Phase 1